ATE237326T1 - Verwendung von 2-methoxyphenyl-1-methyl-5p-methyl-benzoylpyrro -2-acetamido-acetat zur herstellung eines antientzündungsmittels mit vorbeugung von magenhypersekretion und nierenfunktionsstörung - Google Patents
Verwendung von 2-methoxyphenyl-1-methyl-5p-methyl-benzoylpyrro -2-acetamido-acetat zur herstellung eines antientzündungsmittels mit vorbeugung von magenhypersekretion und nierenfunktionsstörungInfo
- Publication number
- ATE237326T1 ATE237326T1 AT97935773T AT97935773T ATE237326T1 AT E237326 T1 ATE237326 T1 AT E237326T1 AT 97935773 T AT97935773 T AT 97935773T AT 97935773 T AT97935773 T AT 97935773T AT E237326 T1 ATE237326 T1 AT E237326T1
- Authority
- AT
- Austria
- Prior art keywords
- methyl
- methoxyphenyl
- prevention
- acetamido
- acetate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IT1997/000209 WO1999007363A1 (en) | 1997-08-08 | 1997-08-08 | Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE237326T1 true ATE237326T1 (de) | 2003-05-15 |
Family
ID=11332729
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97935773T ATE237326T1 (de) | 1997-08-08 | 1997-08-08 | Verwendung von 2-methoxyphenyl-1-methyl-5p-methyl-benzoylpyrro -2-acetamido-acetat zur herstellung eines antientzündungsmittels mit vorbeugung von magenhypersekretion und nierenfunktionsstörung |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1024807B1 (de) |
JP (1) | JP2001513497A (de) |
AT (1) | ATE237326T1 (de) |
DE (1) | DE69721077T2 (de) |
DK (1) | DK1024807T3 (de) |
WO (1) | WO1999007363A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1297140B1 (it) * | 1997-12-24 | 1999-08-03 | Sigma Tau Ind Farmaceuti | Forma cristallina del guaiacil estere dell'acido l-metil-5-p-toluoil- pirrol-2-acetammidoacetico, procedimento per la sua preparazione e |
IT1302898B1 (it) * | 1998-12-03 | 2000-10-10 | Medosan Ricerca Srl | Uso di amtolmetine guacil per la produzione di farmaci ad effettoantiinfiammatorio nelle infiammazioni intestinali. |
JP2006519225A (ja) * | 2003-02-27 | 2006-08-24 | 社団法人芝蘭会 | 依存症治療用医薬組成物 |
CN100390144C (zh) * | 2006-03-29 | 2008-05-28 | 安徽省庆云医药化工有限公司 | 1-甲基-5-对甲苯酰吡咯-2-乙酰氨基乙酸愈创木酚酯的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1162856A (en) * | 1981-07-20 | 1984-02-28 | Dushan M. Dvornik | Aldose reductase inhibition by 1-(4-chlorobenzoyl)-5- methoxy-2-methyl-1h-indole-3-acetic acid |
IT1210673B (it) * | 1982-02-26 | 1989-09-20 | Medosan Ind Biochimi | Antinfiammatoria amidi pirrolacetiche ad attivita' |
US5703073A (en) * | 1995-04-19 | 1997-12-30 | Nitromed, Inc. | Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
IT1278144B1 (it) * | 1995-07-14 | 1997-11-17 | Medosan Ricerca Srl | Impiego dell'amtolmetineguacil (med 15) come farmaco antisecretivo sulla secrezione gastrica e quindi gastroprotettivo. |
-
1997
- 1997-08-08 AT AT97935773T patent/ATE237326T1/de active
- 1997-08-08 WO PCT/IT1997/000209 patent/WO1999007363A1/en active IP Right Grant
- 1997-08-08 DE DE69721077T patent/DE69721077T2/de not_active Expired - Lifetime
- 1997-08-08 JP JP2000506954A patent/JP2001513497A/ja active Pending
- 1997-08-08 DK DK97935773T patent/DK1024807T3/da active
- 1997-08-08 EP EP97935773A patent/EP1024807B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69721077T2 (de) | 2004-02-05 |
DK1024807T3 (da) | 2003-08-04 |
WO1999007363A1 (en) | 1999-02-18 |
JP2001513497A (ja) | 2001-09-04 |
DE69721077D1 (de) | 2003-05-22 |
EP1024807A1 (de) | 2000-08-09 |
EP1024807B1 (de) | 2003-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG105880A (en) | Compounds useful as anti-inflammatory agents | |
DE69004081T2 (de) | Verwendung der Stearidonsäure zur Behandlung von Entzündungserkrankungen. | |
ATE288265T1 (de) | Zusammensetzung zur linderung von störungen der stimmungslage bei gesunden individuen | |
ATE218336T1 (de) | Verwendung von 3-benzoylphenylessigsäuren, deren estern oder amiden zur behandlung von glc1a glaukom | |
DE69526183T2 (de) | 3-benzoylphenylessigsäure-derivate enthaltende topische zusammensetzungen zur behandlung der ophthalmischen entzündungserkrankungen | |
WO2003039454A3 (en) | Beta-secretase inhibitors and methods of use | |
CA2465534A1 (en) | Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof | |
ATE218350T1 (de) | Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen | |
DE69519577D1 (de) | Prednisolonmetasulfobenzoatzusammensetzung zur behandlung von entzündungserkrankung des darmes | |
DE69713300D1 (de) | Benzopyran derivate mit leukotrien-antagonistischer wirkung | |
BG104726A (en) | Novel derivatives of the dihydroxyhexanoic acid | |
ATE270100T1 (de) | Ibuprofenthioester als hemmer der nf-kappa b abhängigen bildung von mediatoren von entzündung und schmerz | |
WO1999048489A3 (en) | Melatonin for delaying the onset of alzheimer's disease and for treating or delaying the onset of other amyloidosis-related diseases/disorders | |
DE69832695D1 (de) | Verwendung von r-enantiomeren nichtsteroidaler entzündungshemmer zur vorbeugung der alzheimerschen krankheit | |
DE69718469T2 (de) | Verbindungen mit wachtumshormon freisetzenden eigenschaften | |
ATE237326T1 (de) | Verwendung von 2-methoxyphenyl-1-methyl-5p-methyl-benzoylpyrro -2-acetamido-acetat zur herstellung eines antientzündungsmittels mit vorbeugung von magenhypersekretion und nierenfunktionsstörung | |
ATE415965T1 (de) | Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung | |
ATE297722T1 (de) | Verwendung von gaba analoga wie gabapentin zur herstellung eines medikaments für die behandlung von entzündungserkrankungen | |
ATE345121T1 (de) | Verwendung von konjugierter linolsäure zur behandlung der erkältung | |
NO20005360L (no) | Sammensetning for fremstilling av brennstoffbriketter | |
FI951759A0 (fi) | Menetelmä 2,2-difluoriketeenisilyyli-O,S-asetaalien ja alfa, alfa-difluori-beta-silyylioksi-1,3-dioksolaani-4-propaanihapon O,S-estereiden valmistamiseksi | |
DE59609977D1 (de) | Trapidil zur verwendung in der therapie von immunmodulatorisch beeinflussbaren krankheitsbildern | |
TR199701605A2 (xx) | S�lfonamid-substit�e edilmi� bile�ikler | |
WO1996020690A3 (en) | 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds | |
MX9704740A (es) | Monomeros de 3,3-(disustituido)ciclohexan-1-ol y compuestos relacionados. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1024807 Country of ref document: EP |